welcome Kazu.
Hello all,
My name is Javier Gracia-Tabuenca. I’m from Spain but have lived now in Tampere (Finland) for 6 years. I finished my PhD in biomedical engineering and stater to work for the FinnGen project.
The FinnGen project aims at collecting the DNA sample of 500.000 (224.580 so far) Fins and enrich them with the info from electronic medical records and drug purchases. https://www.finngen.fi/en
My job is to aid medical doctors to conduct observational studies on this data. I discovered Atlas and the OHDSI community and believe that fits perfectly our needs. So now I’m convincing my organisation to convert the data to the CDM.
If I succeed, I believe that we can take advantage of the many state-oft-the-art analysis tools that OHDISI provides and we can provide to the community the chance to run studies on a data set connected to genetic information, as well as imporve the tools and vocabularies on that area.
Wish me luck !
1 Like
Good luck! And welcome aboard!
Rosa Bianca Gallo
The Hyve
Hey Chistian, Yes:
"The samples are processed using a custom geno-typing array that in addition to normal GWAS markers combines Finnish enriched markers,markers specific to the human leukocyte antigen (HLA) region, pharmacogenomic markersand markers from the industrial partners. In total, the array contains 736,145 probes thatcan genotype 655,973 markers. "
Oh. That’s a lot of markers. You want to bring them all into the OMOP CDM? On average, a patient in our databases have one thousand records or two. Now you’d create a few patients (how many, actually?) with 700k records. You’d turn a tall database into a wide one. The methods may not work, either because of performance or because of statistics failing.
Thoughts?
This is Robert Yerex in Eden Prairie, MN. I am a Senior Data Scientist and Principal Engineer at Optum, part of United Health Group (UHG). I work in R&D and am currently on a project involving using graph DBs to organize and access patient data.
Robert - welcome to OHDSI!
Graph DB sounds very interesting! Would be interested in learning more about your approach.
I am looking into how to apply the CDM to a graph model so that I can make use of the analysis tools. I’ll try to keep updating my progress. 
1 Like
Hey Chistian,
At the moment I have only converted the phenotype data to the CDM (224.580 patients so far, aim is 500.000, 10% of the Finland population). We haven’t yet plan how to include the gennetic information into the CDM. I saw some conversations but there is not yet an standarised way to do this [Genomic Data in the CDM].
Is this the case, or have I missed the CDM’s standars for gennetic data??
Regards
Hello everyone! My name is Diana! I recently joined the OHDSI community and had attended several OHDSI collaborative meetings. I am excited to hear all the cool projects being studied in the OHDSI. I currently work for Dr. Lisa Schilling at the University of Colorado, also working on many cool projects. I have a Masters of Public Health degree concentrating on Epidemiology and Applied Biostatistics. I can use R/R studio, python, SAS, and SQL in SAS. I have some knowledge in project managing! Overall, I am happy to be a part of OHDSI and am excited to be learning so much here. I hope to learn more from everyone!! On my leisure time, I like to run and participate in races, rock climb, martial arts, read/write, and learn new languages. I am also a certified tutor and am part of a language exchange program. I help many students domestically/locally and from many different countries with test prep, science or mathematics, and English, while also learning something from them!
1 Like
Welcome to OHDSI, Diana!
I consult with Health Data Compass at the University of Colorado. And I also support Lisa Schilling and the FDA BEST project there. I look forward to partnering with you on the BEST project. Please feel free to reach out with any OHDSI, EHR or UCD questions 
Hi all, my name is Spyros Kolovos, I work as a health economist at the University of Oxford. Currently, my focus is on musculoskeletal diseases, including rare diseases such as multiple myeloma. I have previously worked on depression and internet-based psychological treatments. The past two years I have been using R to analyse routinely-collected data from UK. I am originally form Greece, but I have been living abroad for the past 10 years.
Thank you for the welcome! David Stumpf here … I’m a Professor Emeritus at Northwestern University Feinberg School of Medicine (NUFSM; Chicago, IL, USA). Resume is at http://woodstockhit.com/stumpf_resume.html. I’m a physician retired from practice but active in mentoring early stage companies as an innovation broker. I’m board certified in neurology, pediatrics and clinical informatics. My interest in OHDSI evolves from a Parkinson Disease project under development at NUFSM which will involve EU and US collaborators. My personal interests concern native graph databases (e.g., Neo4j), network analytics (provider social networks, co-morbidities, etc.) and workflows (event detection, task creation, accountabilities and outcomes, etc.). On the side, I’m a genetic genealogist who works with graph methods to connect genetic family trees to those created from historical data.
I look forward to learning from and conributing to OHDSI!
Hi everyone, I’m a pharmacy student at University of Illinois at Chicago who does research with HemOnc.org (currently partnering with OHDSI). Due to COVID-19, I would like to help where I can, e.g. literature reviews. I could also potentially help with analytical tasks (Python, SQL, some R). Please let me know where I can contribute. Thanks!
Hello OHDSI community!
My name is Anthony. I have been working with OMOP CDM and FHIR resources for about three years (in the US and in France) but never took the time to introduce myself. The current situation made me think it might be a good idea to do so!
As I am more a Python guy, I have been working on a little package (far from being perfect): https://github.com/synaps-tech/rwd_analytics. It needs a bit of documentation though!
Previously, I have also been working on a package to transform MarketScan, Flatiron, IQVIA data using only Python and Dask.
I hope I can support the amazing work you guys are doing with OHDSI!
Anthony
1 Like
Hello all-- I’ve been lurking for some time now, but I thought it may be a good time to introduce myself. I’m a professor in Interactive Arts and Technology at Simon Fraser U. where I teach cognitive approaches to interaction design in rich media systems. My research focus is visual analytics, which takes a cognitive science perspective on the design of interactive information visualization systems for analysis, planning, and individual and group decision-making. I spent a good deal of time focusing on interoperability in emergency planning and response with Canada’s PSTP and the US DHS VACCINE centre. More recently I’ve been applying what I learned to health care with VGH Child and Family Research Network and Molecular You, a personalized health startup. I’d be interested in contributing to the design of data visualizations and methods for working with them.
Hello guys! I’ve been browsing OHDSI and watching OHDSI online videos for quite a while…I also participated in translation of Book of OHDSI into Chinese…so now I can introduce myself as a fan of OHDSI. I’m a clinical pharmacist in Shuguang Hospital in Shanghai, China. I also do research work in clinical pharmacology. I love the idea of standard vocabulary the OHDSI worked on cuz same issue in clinical pharmacology, sometimes we are only using our own data and doing repetitive work that other have already done, and I wonder could we do better if we just accord with each other first…Look forward to hear more and learn more from you all!
Regards.
Hello everyone,
I am an Epidemiologist and currently working as Observational Study Scientist at Actelion/Janssen in Switzerland.
Last year I’ve been involved to transform our observational study data to the OMOP CDM and it was quite a unique and exciting experience for me. Since them I am very keen to learn more about the OHDSI world, get involved in exciting projects (COVID-19 virtual study-a-thon) and meet new people.
In my free time I enjoy travelling, spending time in nature & mountains (hiking, skiing) and reading.